MOTS-c (Mitochondrial Peptide)

MOTS-c and Exercise: What the Published Research Shows

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

Reynolds and colleagues reported in Nature Communications in January 2021 that exercise induces MOTS-c expression, with skeletal-muscle levels rising approximately 12-fold and circulating levels approximately 1.6-fold in humans. The paper characterised MOTS-c as a regulator of age-dependent physical decline, with interventional work performed in mice.

Key facts

Publication
Nature Communications, 20 January 2021
PMID
33473109
Authors
Reynolds JC, Lai RW, Woodhead JST et al.
Skeletal muscle increase
~12-fold after exercise (human)
Circulating increase
~1.6-fold after exercise (human)
Interventional model
Mice
Human component
Observational (measured concentrations)

What was actually measured in humans

The human portion of this work is observational. Researchers measured MOTS-c in skeletal muscle and in circulation before and after exercise, and found expression rose sharply in muscle, roughly 12-fold, with a much more modest rise of about 1.6-fold in the bloodstream. The discrepancy between those two figures is itself informative: it indicates a predominantly local, tissue-level response rather than a systemic endocrine surge.

What was done in mice

The interventional component (administering the peptide and observing outcomes) was performed in mouse models, where the paper reported effects on physical capacity and on markers associated with age-dependent decline. This is the standard structure for work of this kind, and the distinction between the observational human arm and the interventional animal arm is the single most important thing to keep straight when reading it.

Research material referenced

MOTS-C 10mg, third-party HPLC tested

Buy MOTS-C · £24.99

Why exercise induction is mechanistically coherent

Exercise imposes the kind of metabolic stress that AMPK exists to sense, and MOTS-c sits upstream of AMPK. A mitochondrially encoded peptide that rises when mitochondrial demand rises, and that activates the cell's energy sensor, fits the biology rather than sitting oddly against it. The finding is consistent with the mechanism established in 2015 rather than independent of it.

What this does not establish

That a molecule increases naturally during exercise says nothing about what administering it would do. Many things rise with exercise (lactate, cortisol, interleukin-6), and administering them does not reproduce exercise. The inference from 'exercise raises X' to 'X produces the benefits of exercise' is not supported by this paper and the paper does not make it.

Status in sport

MOTS-c is on the World Anti-Doping Agency prohibited list. Any research context involving competitive athletes needs to account for that, and it is a relevant fact about the compound regardless of the research question.

Frequently asked questions

Does MOTS-c reproduce the effects of exercise?

Nothing in the published work establishes that. The paper reports that exercise induces MOTS-c; that is a different claim from the reverse.

Why did muscle levels rise so much more than blood levels?

The roughly 12-fold tissue rise against a 1.6-fold circulating rise indicates a predominantly local response rather than a systemic hormonal one.

Was the human work interventional?

No. The human component measured concentrations before and after exercise. Administration studies in that paper were conducted in mice.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More MOTS-c (Mitochondrial Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.